Publications - The
'90s
Publications -
The '80s
Legend:
(a) - authorship
alphabetical by consensus
(s) - student
(f) - research
fellow under my supervision
(g) - group authorship
by consensus of investigators
In Press
Yaffe MJ, Wolfson C, Lithwick M, Weiss D. (2008). Development
and validation of a tool to improve physician identification of elder abuse:
The elder abuse suspicion index (EASI). In Press: Journal of Elder Abuse and
Neglect.
Appeared
(f)Poppe AY, Wolfson C, Zhu B. (2008). Prevalence of multiple sclerosis in Canada: A
systematic review. Canadian Journal of Neurological
Sciences, 35: 593-601.
(f)Al-Hashel J, Besterman AD, Wolfson C, Al-Hajeri A. (2008). The prevalence of
Multiple Sclerosis in the
Pugliatti M, Harbo HF, Holmoy T, Kampman MT, Myhr K-M, Riise T, Wolfson C.
(2008) Environmental risk factors in multiple sclerosis. Acta
Neurologica Scandinavica,
117 (Suppl. 188): 34-40.
(s)Keezer M, Yu A,
Zhu B, Wolfson C, Côté R. (2008). Blood Pressure and Antihypertensive Therapy as Predictors of
Outcome in Acute Ischemic Stroke. Cerebrovascular
Disease, Jan 23;25(3):202-208.
(s)Oremus M, Wolfson
C, Vandal AC, Bergman H, Xie Q. (2007). Caregiver acceptance of adverse effects and use of cholinesterase
inhibitors in Alzheimer's disease. Can J Aging, 26(3):205-212.
Rockwood K, Howlett S,
Fisk J, Darvesh S, Tuokko
H, Hogan DB, Wolfson C. (2007). Lipid-Lowering
Agents and the Risk of Cognitive Impairment That Does Not Meet Criteria for
Dementia, in Relation to Apolipoprotein E Status.
Neuroepidemiology, 29:201-207.
Yaffe MJ, Weiss D, Wolfson C, Lithwick M. (2007). Detection and prevalence of abuse of
older males: Perspectives from family practice. Journal of Elder Abuse and
Neglect, 19(1-2):47-60.
Monette J, Champoux N, Fournier L, Monette
M, Wolfson C, Galbaud du Fort G, Sourial N, Le
Cruguel JP, Gore B. (2007). Effect of an interdisciplinary educational program
on antipsychotic prescribing among nursing home residents with dementia. International Journal of
Geriatric Psychiatry. Online Date: October 29, 2007.
Bergman H, Ferrucci L, Guralnik J, Hogan D, Hummel S, Karunananthan
S, Wolfson C. (2007) Frailty, an emerging research and clinical
paradigm: Issues and controversies. Journals of
Gerontology. Medical Sciences, 2007 Jul;62(7):731-7.
Dupuis J, Weiss, DB, Wolfson C.
(2007). Gender
and transportation access among community-dwelling seniors. Canadian Journal on
Aging, 2007 Summer;26(2):149-58.
(s)Roberts KC, Wolfson
C, Payette, H. (2007). Predictors of
Nutritional Risk in Community-dwelling Seniors. Canadian Journal of Public Health,
2007;98(4):331-36.
(s)Oremus M, Wolfson
C, Bergman H, Vandal A. (2007). Physicians’ efficacy
requirements for prescribing medications to persons with Alzheimer’s disease.
Canadian Journal on Aging, 2007 Summer;26(2):139-48.
(s)Postuma RB, Wolfson
C, Rajput A, Stoessl
AJ, Martin WR, Suchowersky O, Chouinard
S, Pannisset M, Jog MS, Grimes DA, Marras C, Lang AE. (2007). Is there seasonal variation in risk of
Parkinson’s disease? Movement Disorders, Jun 15;22(8):1097-101.
(s)Quail, J, Addona
V, Wolfson C, Podoba J, Lévesque L, Dupuis
J. (2007).
Association of self-rated health in a community dwelling cohort
of seniors 75 years of age and over. European Journal of Aging, 4:45-55. Online Date: February 17, 2007.
(s)Auger C, Demers L, Derosiers J, Giroux
F, Ska B, Wolfson C (2007). Applicability of a toolkit
for geriatric rehabilitation outcomes. Disability and Rehabilitation,
29(2):97-109.
Wolfson C, with Johnson
RT, Bradley WG, Ritz BE, Ritz BR, Rocca WA, Shefner JM (2006). Amyotrophic Lateral Sclerosis in Veterans: Review of the Scientific
Literature. IOM (Report of the Institute of Medicine of
the National Academies) National Academy Press.
Bergman H, Hogan D, Karunananthan
S, Béland F, Wolfson C (2006). Frailty. The Encyclopedia of Aging, 4th
edition, 1: 423-426.
(s)Ehrensperger E, Minuk J. Durcan L, Mackey A, Wolfson
C, Fontaine A-M, Côté R (2005). Predictive value of soluble
intercellular adhesion molecule - 1 for risk of ischemic events in individuals
with cerebrovascular disease. Cerebrovascular
Diseases, 20(6):456-62.
(s)Oremus M, Cosby JL, Wolfson C (2005). A Hybrid
Qualitative Method for Pretesting Questionnaires - The Example of a
Questionnaire to Caregivers of Alzheimer Disease Patients. Research in Nursing and Health, 28:419-430.
Demers L, Desrosiers J, Ska B, Wolfson C, Nikolova R, Pervieux I, Auger C. (2005). Assembling a toolkit to measure geriatric rehabilitation outcomes. American Journal of Physical Medicine and Rehabilitation, 84(6):460-472.
(s)Chamandy N, Wolfson
C. (2005). Underlying
causes of death in demented and non-demented elderly Canadians. Neuroepidemiology, 25:75-84.
Champoux N, Monette
J, Monette M, Galbaud du
Fort G, Wolfson C, Le Cruguel J-P. (2005) Use of neuroleptics. Study of institutionalized
elderly people in Montreal, Que. Canadian
Family Physician, 51:696-697.
Rockwood K, Howlett SE, MacKnight C, Beattie
BL, Bergman H, Hebert R, Hogan DB, Wolfson C,
McDowell I, for the Frailty
Investigator’s Group of the Canadian Study of Health and Aging. (2004). Prevalence, attributes and outcomes
of fitness and frailty in community-dwelling older adults: report from the
Canadian Study of Health and Aging. Journal
of Gerontology - Series A, Biological sciences and
medical sciences, 59(12):1310-1317.
Bergman H, Béland F,
Karunananthan S, Hummel S, Hogan
D, Wolfson C, pour l’Initiative canadienne sur la fragilité et le
vieillissement (2004). Développement
d’un cadre de travail pour comprendre et étudier la fragilité/Developing a Working Framework
for Understanding Frailty. Gérontologie et Société, 109:15-29.
(s)Oremus M, Wolfson
C (2004). Female
specialists were more likely to respond to a postal questionnaire about drug
treatments for Alzheimer disease. Journal of Clinical
Epidemiology, 57(6):620-623.
Demers L, Ska B, Desrosiers J, Alix C, Wolfson
C (2004). Development of a conceptual
model for the assessment of geriatric rehabilitation outcomes. Archives of Gerontology and Geriatrics,
38(3):221-237.
Zunzunegui MV, Koné A, Johri M,
Béland F, Wolfson C, Bergman H (2004). Social networks and self reported health in
two French speaking Canadian community dwelling populations over 65. Social Science
and Medicine, 58(10):2069-81.
(f)Moore FGA, Wolfson C,
Alexandrov L, Lapierre Y (2004). Do general and Multiple
Sclerosis-specific quality of life instruments differ? Canadian Journal of
Neurological Sciences, 31(1):64-71.
Hogan DB, MacKnight C., Bergman H, Wolfson C (as member of the Steering Committee), on behalf of the Steering Committee, Canadian
Initiative on Frailty and Aging. (2003). Models, definitions, and criteria of frailty. Aging Clinical and Experimental Research,
15 (Suppl. to No. 3):3-29.
Hébert R, Dubois M.-F, Wolfson
C, Chambers L, Cohen C (2003). Facteurs associés à l’institutionnalisation à
long terme de personnes âgées démentes.
Démence Sévere : L’Institutionnalisation
des patients. Maladie d’Alzheimer et
déclin cognitif. Recherche et
pratique clinique, Vol 8: 136-141.
Monette J, Monette M, Champoux
N, Galbaud du Fort G, Wolfson C. (2003). Use of neuroleptics among
institutionalized elderly: prevalence, efficacy and adverse events. Revue de Gériatrie, Tome 28 (3):259-268.
Kakuma R, Galbaud du Fort G, Arsenault L, Perrault A,
Platt RW, Monette J, Moride Y, Wolfson C. (2003). Delirium in Older Emergency Department Patients
Discharged Home: Effect on Survival. Journal of the American Geriatrics
Society, 51(4):443-450.
Perrault A, Wolfson C, Egan M, Rockwood K,
Hogan D. (2002). Prognostic Factors for Functional Independence in Older Adults
with Mild Dementia: Results from the Canadian Study of Health and Aging. Alzheimer’s Disease and Associated Disorders,
16(4):239-247.
(g)The Canadian Study of Health and Aging Working
Group. (2002). Patterns and Health Effects of Caregiving
for People with Dementia: The Impact of Changing Cognitive and Residential
Status. The Gerontologist, 42:643-652.
Wolfson C, Talbot P (2002). Bacterial infection as a cause of multiple sclerosis. An invited commentary. The Lancet, 360:352-353.
Wolfson C, Wolfson DB.
(2002) Survival with dementia, from onset: shorter than previously reported. Research
and Practice in Alzheimer’s Disease. Vol
6:114-120.
(f)Demers L, Monette M,
Descent M, Jutai J, Wolfson C (2002). The
Psychosocial Impact of Assistive Devices (PIADS): Translation and Preliminary
Psychometric Evaluation of a Canadian-French Version. Quality of Life
Research, 11(6):583-592.
Rockwood K, Brown M, Merry H, Sketris I, Fisk
J; Wolfson C (as member of the Vascular Cognitive Impairment Investigators
of the Canadian Study of Health and Aging). (2002). Societal
Costs of Vascular Cognitive Impairment in Older Adults. Stroke,
33(6):1605-1609.
Wolfson C, Oremus M, Shukla V, Momoli F, Demers L,
Perrault A, Moride Y. (2002). Donepezil
and Rivastigmine in the Treatment of Alzheimer’s Disease: A Best Evidence Synthesis of the
Evidence for Efficacy and Cost-Effectiveness. Clinical Therapeutics,
24(6):862-866.
(f)Moore F. G.A. and Wolfson C. (2002). Human Herpes Virus 6 and Multiple Sclerosis. Acta Neurologica Scandinavica, 106 (2):63-83.
(f)Marrie RA, Wolfson C. (2002).
Multiple Sclerosis and Epstein-Barr Virus: A Review. Canadian
Journal of Infectious Diseases, 13(2):111-118.
Wolfson C, Perrault A, Moride Y, Esdaile J.M, Abenhaim L, Momoli F. (2002). A
case-control analysis of nonsteroidal
anti-inflammatory drugs and Alzheimer's disease: are NSAIDs protective? Neuroepidemiology, 21:81-86.
Rockwood K, Macknight C, Kirkland S, Hogan D,
Merry H, Verrault R, Wolfson C, McDowell I.
(2002). Use of lipid lowering agents, indication bias and the
risk of dementia in community-dwelling elderly people. Archives of
Neurology, 59:223-227.
Demers L., Monette M., Lapierre Y., Douglas A., Wolfson C. (2002). Reliability, validity, and applicability of the Quebec
User Evaluation of Satisfaction with assistive Technology (QUEST 2.0) for
adults with Multiple Sclerosis. Disability and Rehabilitation
24:21-30.
Rouah F, Wolfson C.
(2001). An ad-hoc method for obtaining the age at onset of
dementia in the CSHA database. International Journal of Psychogeriatrics, Vol 13
(Suppl. 1):57-70.
Correa J, Perrault A, Wolfson C. (2001). Reliable individual
change scores on the 3MS in older persons with dementia: Results from the
Canadian Study of Health and Aging. International Journal of Psychogeriatrics, 13 (Suppl. 1):71-78.
(g)The Canadian Study of Health and Aging Working
Group. (2001). Disability and frailty among elderly Canadians: a
comparison of six surveys. International Journal of Psychogeriatrics,
Vol 13 (Suppl. 1):159-167.
Rockwood K, Wolfson C, McDowell I. (2001). The Canadian Study of
Health and Aging: organizational lessons from a national, multi-centre,
epidemiologic study. International Journal of Psychogeriatrics,
Vol 13 (Suppl. 1):233-237.
(f)Marrie RA, Wolfson C. (2001).
Multiple sclerosis and varicella zoster infection: A
review. Epidemiology and Infection, 127:315-325.
(s)Egan M, Wolfson C, Moride Y, Monette J. (2001). High daily doses of benzodiazepines
among Quebec seniors: prevalence and correlates. BMC Geriatrics 1:4.
Hébert R, Dubois M-F, Wolfson
C, Chambers L, Cohen C. (2001). Factors associated with long-term
institutionalization of older people with dementia. Data from
the Canadian Study of Health and Aging (CSHA). Journal of
Gerontology: Medical Sciences, 56A(11):M693-699.
Wentzel C, Rockwood K, MacKnight C, Hachinski V, Hogan
DB, Feldman F, Ostbye T, Wolfson C, Gauthier
S, Verreault R, McDowell I. (2001). Progression of
Impairment in Patients with Vascular Cognitive Impairment Without
Dementia. Neurology, 57(4):714-716.
Wolfson C. [Invited
Editorial]. Multiple Sclerosis and antecedent infections.
Epidemiology, 12 (3):298-299, May 2001.
Wolfson C, Wolfson DB, Asgharian M, M'Lan C for the
Clinical Progression of Dementia Working Group. (2001). A
re-evaluation of the duration of survival from the onset of dementia. New
England Journal of Medicine, 344(15):1111-1116. This article was the lead
article with an editorial "Aging and Public Health Effects of
Dementia" by Dr. C Kawas and Dr. Brookmeyer.
Confavreux C, Suissa S, Saddier P, Bourdes V, Vukusic S for the
Vaccines in Multiple Sclerosis Study Group (2001). Vaccinations and the risk
for relapse in multiple sclerosis. New England Journal of Medicine,
344:319-326. (I was a member of the Vaccines in Multiple Sclerosis Study group
through my role as the statistician on the Design and Protocol Committee).
Wolfson C, Moride Y, Perrault A, Momoli F,
Demers L, Oremus M (2001). Review: Donepezil, metrifonate, rivastigmine, and
Gingko Biloba are more effective than placebo in Alzheimers's Disease. Evidence-Based
Mental Health, 4(1)24- with accompanying expert commentary by Dr. J. Pearck, The Fulbrook Centre,
Oxford U.K. A modified version with commentary also appears in the
American College of Physicians Journal Club. Vol 134 (1).
Oremus M, Wolfson C, Perrault A, Demers L, Momoli
F, Moride Y. (2001). Interrater reliability of the
modified Jadad quality scale for systematic reviews
of Alzheimer's disease drug trials. Dementia and Geriatric Cognitive
Disorders, 12:232-236.
(f)Demers L, Oremus M, Perrault A, Wolfson C.
(2000). A review of outcome measurement instruments in Alzheimer's
disease drug trials: Introduction. Journal of Geriatric Psychiatry and
Neurology, 13(4):161-169.
(f)Demers L, Oremus M, Perrault A, Champoux
N, Wolfson C. (2000). A review of outcome measurement instruments
in Alzheimer's disease drug trials: Psychometric properties of functional and
quality of life scales. Journal of Geriatric Psychiatry and Neurology,
13(4):170-180.
Perrault A, Oremus M, Demers L, Vida S, Wolfson C. (2000). A
review of outcome measurement instruments in Alzheimer's disease drug trials:
Psychometric properties of behavior and mood scales. Journal of Geriatric
Psychiatry and Neurology, 13(4):181-196.
Oremus M, Perrault A, Demers L, Wolfson C. (2000). A review of
outcome measurement instruments in Alzheimer's disease drug trials:
Psychometric properties of global scales. Journal of Geriatric Psychiatry
and Neurology, 13(4):197-205.
(s)Egan M, Wolfson C, Moride Y, Monette J. (2000). Do patient factors alter the
relationship between physician characteristics and use of long-acting
benzodiazepines? Journal of Clinical Epidemiology, 53(11):1181-1187.
(s)Koutsavlis A, Wolfson C. (2000). Elements of mobility as predictors of survival in demented adults.
Chronic Diseases in Canada, 21(3):93-103.
Sternberg SA, Wolfson C,
Baumgarten M. (2000). Undetected dementia in the community-dwelling
elderly: The Canadian Study of Health and Aging. Journal of the American
Geriatrics Society, 48(11):1430-1439.
Robbins JM, Wolfson CM, Bergman H, Clarfield
AM, Kleiman S, Bilker W, Baumgarten
M. (2000). Agreement between elderly subjects and proxy
informants on history of surgery and childbirth. Journal of the
American Geriatrics Society, 48(8):975-984.
(s)Egan M, Moride Y, Wolfson C, Monette J. (2000). Long-term continuous use of
benzodiazepines by older adults in Quebec: Prevalence, Incidence and Risk
Factors. Journal of the American Geriatrics Society, 48(7):811-816.
Côté R, Wolfson C,
Solymoss S, Mackey A, Leclerc
J, Simard D, Bourque F, Léger B. (2000). Hemostatic
markers in patients at risk of cerebral infarction. Stroke,
31:1856-1862.
(g)The Canadian Study of Health and Aging Working Group
(2000). The incidence of dementia in Canada. Neurology,
55 (1):66-73.
(f)Marrie RA, Wolfson C, Sturkenboom MCJM, Gout O, Heinzlef
O, Roullet E, Abenhaim L.
(2000). Multiple Sclerosis and Antecedent Infections: A Case-Control Study. Neurology,
54 (12):2307-2310.
Zunzunegui MV, Gutiérrez Cuadra P, Béland F, Del Ser T, Wolfson C.
(2000). Development of simple cognitive function measures in
a community dwelling population of elderly in Spain. International Journal
of Geriatric Psychiatry, 12 (2):130-140.